Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a controlled, open study designed to compare the effects of dual-release
hydrocortisone preparations versus conventional glucocorticoid therapy on clinical,
anthropometric parameters, metabolic syndrome, hormonal profile, bone status, quality of
life, reproductive, sexual and psychological functions and treatment compliance in patients
affected by congenital adrenal hyperplasia due to 21 OH deficiency.